
11 - 50 employees
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
💰 $43M Series B on 2021-11
Biotechnology • Pharmaceuticals • Healthcare Insurance
Prilenia is dedicated to developing new treatments for patients and families facing neurodegenerative diseases and neurodevelopmental disorders, such as Huntington’s disease and amyotrophic lateral sclerosis (ALS). They focus on harnessing the brain's neuroprotective capabilities, particularly through the activation of the sigma-1 receptor (S1R), to restore impaired pathways in the brain. Prilenia is advancing scientific research and exploring potential treatments to provide hope and improve the lives of patients and their families.
🕒 June 25
Medical Science Liaison involved in advancing therapies for neurodegenerative diseases. Engaging with KOLs and supporting clinical trials in the U.S. and Canada.
🕒 June 8
🇺🇸 United States – Remote
💰 $43M Series B on 2021-11
⏰ Full Time
🟠 Senior
🔧 QA Engineer (Quality Assurance)
🕒 March 13
Regional Clinical Trial Manager managing clinical trial operations in neurodegeneration for biopharmaceutical company. Requires strong experience in clinical research and project management.
🕒 November 17, 2025
Vice President of Clinical Operations leading global pivotal trials for neurodegenerative diseases. Driving strategy and operational excellence in a flexible, remote-focused biotech company.